Anti-INFa [ST29]
Invented by Prof Joyce Taylor-Papadimitriou from King's College London
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (3)
- Inventor Info
Info
| Catalogue Number | 151162 |
| Applications | ELISA Fn |
| Antigen/Gene or Protein Targets | Interferon alpha (INFa) |
| Reactivity | Human |
| Relevance | INFa is a type I interferon that is involved in the innate immune response against viral infections. ST29 distinguishes between sub-species of human INFa and can be used to detect INF oligomers. Neutralises anti-viral activity of INF. |
| Host | Mouse |
| Immunogen | Human interferon (HuIFN) produced by Namalwa cells (HuIFN-aN) |
| Positive Control | PMA stimulated human peripheral blood mononuclear cells |
| Subclass | IgG1 |
| Molecular Weight (kDa) | 18-25 |
| Myeloma Used | P3X63Ag8.653 |
| Recommended Growing Conditions | RPMI 1640 + 10% FCS |
| Strain | Balb/c |
| Research Area | Virology |
References: 3 entries
Doğanay et al. 2017. Integr Biol (Camb). 9(11):857-867. PMID: 29098213.
Gainey et al. 2008. J Virol. 82(19):9369-80. PMID: 18667520.
Shearer et al. 1984. J Immunol. 133(6):3096-101. PMID: 6491281.
Add a reference
References: 3 entries
Doğanay et al. 2017. Integr Biol (Camb). 9(11):857-867. PMID: 29098213.
Gainey et al. 2008. J Virol. 82(19):9369-80. PMID: 18667520.
Shearer et al. 1984. J Immunol. 133(6):3096-101. PMID: 6491281.
Add a reference
